Description: Osteopore Limited designs, develops, and markets bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications. It specializes in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing. The company offers Osteoplug, a bioresorbable implant, which is used for covering trephination burr holes in neurosurgery; Osteomesh that is used in craniofacial surgery to repair various types of fractures; and Osteostrip for filling the void following a craniotomy. It operates in Singapore, Malaysia, South Korea, Vietnam, and internationally. The company was founded in 2003 and is headquartered in Singapore.
Home Page: www.osteopore.com
OSX Technical Analysis
No. 09-06, 2 Tukang Innovation Grove
Singapore,
618305
Singapore
Phone:
65 6250 2817
Officers
| Name | Title |
|---|---|
| Mr. Kei Wei Leong | Exec. Chairman |
| Mr. Khoon Seng Goh | Chief Exec. Officer |
| Dr. Jing Lim | COO & CTO |
| Ms. Deborah Ho AGIA, B.Com. | Company Sec. |
Exchange: AU
Country: AU
Currency: Australian Dollar (A$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 6.5797 |
| Price-to-Sales TTM: | 17.9063 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |